title: Inotropic support in the NICU: ever more compounds in search of guidance? Commentary on J. Esch et al.: differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation (Neonatology 2012;101:192–200) and M.P. De Carolis et al.: levosimendan in two neonates with ischemic heart failure and pulmonary hypertension (Neonatology 2012;101:201–205).
authors: Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
authors: Liesbeth
authors: L
authors: Thewissen
authors: Karel
authors: K
authors: Allegaert
mesh_terms: D000818:Animals; D002302:Cardiac Output / Q000187:drug effects*; D002316:Cardiotonic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D005260:Female; D005311:Fetal Hypoxia / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology* / Q000627:therapeutic use*; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy*; D010100:Oxygen / Q000008:administration & dosage*; D011724:Pyridazines / Q000494:pharmacology* / Q000627:therapeutic use*; D000077464:Simendan; D013552:Swine / Q000502:physiology*
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan; D010100:Oxygen